SPECT (single photon emission computer tomography) finds source of migraines:
This article was originally published in Clinica
Migraine may one day be diagnosed by looking for inflammation of the membrane surrounding the brain using single photon emission computerised tomography (SPECT), US neurologists revealed at the American Academy of Neurology's meeting in Toronto, last month. The technique could also be used to find new pain-relieving drugs. Researchers at Johns Hopkins School of Medicine in Baltimore injected patients suffering a migraine attack with a radiolabelled protein and followed its path using SPECT. The protein leaked from the blood into swollen tissue, identifying the meninges as the source of the migraine.
You may also be interested in...
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.